Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
BPC-157, sometimes called Body Protection Compound-157 or "Wolverine peptide," is a synthetic peptide chain based on a protein found in human gastric juice, and it is promoted for accelerating healing of tendons, ligaments, muscle, and gut tissue. Despite the hype, it is not approved by the FDA for any medical use, it was placed on the FDA's list of substances with safety risks for compounding, and it has been banned by the World Anti-Doping Agency since 2022. Nearly all of the encouraging evidence comes from animal studies, meaning long-term human safety, proper dosing, cancer risk, and product purity remain largely unknown, and unregulated "research only" vials sold online may be contaminated or mislabeled. Whether it is safe for you depends on several important factors, including your health history, medications, and what symptoms you are actually trying to treat, so see below to understand more before you consider using it.
If you are thinking about BPC-157 because of nagging pain, a slow-healing injury, or ongoing gut trouble, the smarter first step is to clarify what is causing your symptoms rather than experimenting with an unapproved peptide. A free, instant, online symptom check takes only a few minutes, asks the kinds of questions a clinician would ask, and helps you understand possible causes and which type of care to seek next. Knowing what you are dealing with puts you in a far better position to have an informed conversation with a doctor and to avoid risky shortcuts.
Last reviewed for medical accuracy: 09/26/2026
BPC-157 (Body Protection Compound-157) peptides are short chains of amino acids derived from a naturally occurring protein in the human stomach. Researchers first identified BPC-157 for its potential role in:
Unlike many drugs, BPC-157 peptides are not yet approved by major health agencies such as the U.S. Food and Drug Administration (FDA). Most of the published research has been done in animals, with only a handful of small, early-phase human studies or anecdotal reports in athletic and clinical communities.
While the precise mechanisms remain under investigation, BPC-157 peptides appear to:
These actions have prompted interest in BPC-157 for conditions ranging from tendon injuries to gastrointestinal disorders.
Much of the excitement around bpc 157 peptides comes from preclinical (animal) studies and early human reports. Potential benefits under investigation include:
Keep in mind that while these results are promising, large-scale, placebo-controlled human trials are still needed to confirm how well bpc 157 peptides work in people.
Because BPC-157 peptides remain largely unregulated and understudied in humans, their safety profile is not fully established. Reported side effects are generally mild but may include:
More serious risks are theoretical but could involve:
Until more robust human data are available, long-term safety remains uncertain.
BPC-157 peptides are often sold as “research chemicals.” This means:
From a legal standpoint:
Always verify the source and check your local regulations before considering any peptide therapy.
Before using bpc 157 peptides—or any experimental therapy—consider the following steps:
If you experience anything concerning, perform a free, online symptom check, using the doctor approved Ubie Symptom Checker to help guide your next steps.
While animal studies are promising, human data on bpc 157 peptides are scarce:
Researchers and clinicians agree that more rigorous studies are needed before BPC-157 can be considered a mainstream medical therapy.
Based on current evidence:
If you decide to try bpc 157 peptides, do so with caution:
BPC-157 peptides hold intriguing potential for tissue repair and inflammation control, but most of what we know comes from animal research. Human safety and efficacy data are still emerging. If you’re considering bpc 157 peptides:
For non-urgent health concerns, remember you can perform a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance.
Always speak to a doctor before starting any new therapy, especially if you have serious or life-threatening conditions. Your healthcare provider can help you make the safest, most informed decision.
(References)
* Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Prtoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB, Sikiric P. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021;12:627533. doi: 10.3389/fphar.2021.627533. Epub 2021 Jun 29. PMID: 34267654; PMCID: PMC8275860.
* DeFoor MT, Dekker TJ. Injectable Therapeutic Peptides-An Adjunct to Regenerative Medicine and Sports Performance? Arthroscopy. 2025 Feb;41(2):150-152. doi: 10.1016/j.arthro.2024.09.005. Epub 2024 Sep 10. PMID: 39265666.
* Lee E, Walker C, Ayadi B. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study. Altern Ther Health Med. 2024 Oct;30(10):12-17. PMID: 39325560.
* Józwiak M, Bauer M, Kamysz W, Kleczkowska P. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals (Basel). 2025 Jan 30;18(2). doi: 10.3390/ph18020185. Epub 2025 Jan 30. PMID: 40005999; PMCID: PMC11859134.
* Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025 Sep;31(5):20-24. PMID: 40131143.
* Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025 Nov;21(4):485-495. doi: 10.1177/15563316251355551. Epub 2025 Jul 31. PMID: 40756949; PMCID: PMC12313605.
* McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025 Dec;18(12):611-619. doi: 10.1007/s12178-025-09990-7. Epub 2025 Aug 12. PMID: 40789979; PMCID: PMC12446177.
* Mayfield CK, Bolia IK, Feingold CL, Lin EH, Liu JN, Rick Hatch GF, Gamradt SC, Weber AE. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. Am J Sports Med. 2026 Jan;54(1):223-229. doi: 10.1177/03635465251357593. Epub 2026 Jan 1. PMID: 41476424.
* Rahman OF, Lee SJ, Seeds WA. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. 2026 Jan 1;10(1). doi: 10.5435/JAAOSGlobal-D-25-00236. Epub 2026 Jan 2. PMID: 41490200; PMCID: PMC12753158.
* Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026 Aug;56(8):1921-1935. doi: 10.1007/s40279-026-02437-0. Epub 2026 Apr 12. PMID: 41966639.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.